# Safety of Celecoxib in Patients With Crohn's Disease

> **NCT00177866** · PHASE4 · TERMINATED · sponsor: **University of Pittsburgh** · enrollment: 28 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** Celebrex
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00177866
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-12
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 28 (ACTUAL)
- **Why stopped:** We were unable to get additional funding to complete study.
- **Last updated:** 2016-08-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00177866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00177866, "Safety of Celecoxib in Patients With Crohn's Disease". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00177866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*